Benjamin M. Gaston, MD, is Chief of the Division of Pulmonary Medicine and Chief of the Division of Pediatric Allergy and Immunology at University Hospitals Rainbow Babies & Children's Hospital and UH Cleveland Medical Center. He is Professor, Pediatrics, Case Western Reserve University School of Medicine.
He is board certified in pediatric pulmonology. Dr. Gaston’s special interests include pediatric airway diseases such as asthma and cystic fibrosis, primary ciliary dyskinesia, pediatric lung diseases and aerodigestive disorders.
Dr. Gaston earned his undergraduate degree at the University of Virginia, Charlottesville, Va., and received his medical degree from the University of Virginia School of Medicine. Dr. Gaston completed a residency in pediatrics at Naval Regional Medical Center and was Chief Resident in pediatrics and a teaching fellow at Uniformed Services University of the Health Sciences, both in Bethesda, Md. He continued his postgraduate training as a fellow in pulmonary medicine at Children's Hospital, Boston, Mass., followed by a clinical and research fellowship at Brigham and Women's Hospital, also in Boston.
Prior to joining the UH Rainbow staff in 2012, Dr. Gaston was Professor of Pediatrics at the University of Virginia School of Medicine. His previous positions include attending physician University of California, San Diego, Medical Center, San Diego, Calif.; attending physician, Division Head and Cystic Fibrosis Clinic Director, Naval Hospital, San Diego; and Chairman of the Department of Pediatrics, Naval Hospital, Camp Lejeune, Jacksonville, N.C.
Dr. Gaston currently is Principal Investigator on several studies related to pediatric asthma, cystic fibrosis, pulmonary hypertension and apnea hypertension in children. He has published more than 125 articles on pediatric pulmonary problems in peer-reviewed journals and authored more than a dozen chapters in medical textbooks.
Dr. Gaston is on the board of the American Journal of Respiratory and Critical Care Medicine and Pediatric Pulmonology and a reviewer for numerous medical journals, including American Journal of Physiology, Lung Cellular and Molecular Physiology; American Journal of Respiratory and Critical Care Medicine; and New England Journal of Medicine. He is a frequent invited presenter at medical conferences locally, nationally and internationally, speaking on basic research and the diagnosis and treatment of pediatric asthma and other airway diseases.
He has been a member of the Lung Cellular, Molecular, and Immunobiology Study Section of the National Heart, Lung, and Blood Institute. Dr. Gaston is a Fellow of the American Academy of Pediatrics and a member of the American Thoracic Society, American Association for the Advancement of Science and Christian Medical Society.
He holds 10 patents on products related to the diagnosis and treatment of pediatric asthma, cystic fibrosis and other airway diseases.
Honors and Recognition
Fellow, American Academy of Pediatrics
Apnea hypertension in children
- Cystic Fibrosis
- Lung Diseases
- Primary Ciliary Dyskinesia
- Pulmonary Diseases
Patient Satisfaction Reviews
0 out of 5
- Pediatric Pulmonology - American Board of Pediatrics
Brigham And Women's Hospital (1992 - 1993)
Fellowship | Pulmonary Disease
Pulmonary Disease - Boston Children's Hospital (1990 - 1993)
Residency | Pediatrics
Pediatrics - Walter Reed National Military Medical Center (1986 - 1988)
Internship | Pediatrics
Pediatrics - Walter Reed National Military Medical Center (1983 - 1984)
University Of Virginia School Of Medicine (1983)
University Of Virginia (1979)
Pediatric asthma, severe asthma, pulmonary hypertension, apnea, primary ciliary dyskinesia
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Benjamin Mctyeire Gaston did not disclose any Outside Relationships with Industry.